Reversable RNA Anticoagulant Development, Contract Production, and Pre-Clinical Testing
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Helixomer, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Thomas LaBean
Fiscal Year
2023
Region
Research Triangle
Project Description:
Helixomer of Raleigh received $250,000 to advance a novel RNA-based anticoagulant therapy with reversal agents for intravenous use in human healthcare.